Clinical evaluation of an insulin resistance improving agent, AD-4833, in patients with non-insulin-dependent diabetes mellitus (NIDDM) on treatment with an SU drug. - Kaneko,T.; Baba,S.; Toyota,T.; Akanuma,Y.; Sakamoto,N.; Shigeta,Y.; Shichiri,M.; Nakano,S. (Jpn J Clin Exper Med, 1997)